Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Monash IVF Group Ltd ( (AU:MVF) ) just unveiled an announcement.
Monash IVF Group Limited announced the late lodgement of an Appendix 3Z following the resignation of Michael Knaap as Chief Executive Officer and Managing Director. The company acknowledged the oversight and emphasized its commitment to compliance with ASX disclosure obligations, stating that it will implement further measures to prevent future occurrences.
The most recent analyst rating on (AU:MVF) stock is a Buy with a A$1.55 price target. To see the full list of analyst forecasts on Monash IVF Group Ltd stock, see the AU:MVF Stock Forecast page.
More about Monash IVF Group Ltd
Monash IVF Group Limited operates in the healthcare industry, specializing in reproductive health services. The company focuses on providing in-vitro fertilization (IVF) and related fertility treatments, catering to individuals and couples seeking assistance with conception.
Average Trading Volume: 4,789,687
Technical Sentiment Signal: Sell
Current Market Cap: A$243.5M
For detailed information about MVF stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue